Systematic review with network meta-analysis: comparative effectiveness and safety of strategies for preventing NSAID-associated gastrointestinal toxicity (Q36001198)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Systematic review with network meta-analysis: comparative effectiveness and safety of strategies for preventing NSAID-associated gastrointestinal toxicity	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

0 references

Systematic review with network meta-analysis: comparative effectiveness and safety of strategies for preventing NSAID-associated gastrointestinal toxicity (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

systematic review

1 reference

based on heuristic

inferred from title

Francis Ka-Ming Chan

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27121479 AND SRC:MED&resulttype=core&format=json

4 June 2020

author name string

J Q Yuan

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27121479 AND SRC:MED&resulttype=core&format=json

4 June 2020

K K F Tsoi

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27121479 AND SRC:MED&resulttype=core&format=json

4 June 2020

M Yang

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27121479 AND SRC:MED&resulttype=core&format=json

4 June 2020

J Y Wang

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27121479 AND SRC:MED&resulttype=core&format=json

4 June 2020

D E Threapleton

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27121479 AND SRC:MED&resulttype=core&format=json

4 June 2020

Z Y Yang

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27121479 AND SRC:MED&resulttype=core&format=json

4 June 2020

B Zou

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27121479 AND SRC:MED&resulttype=core&format=json

4 June 2020

C Mao

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27121479 AND SRC:MED&resulttype=core&format=json

4 June 2020

J L Tang

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27121479 AND SRC:MED&resulttype=core&format=json

4 June 2020

language of work or name

0 references

publication date

28 April 2016

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

Alimentary Pharmacology & Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27121479 AND SRC:MED&resulttype=core&format=json

4 June 2020

43

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27121479 AND SRC:MED&resulttype=core&format=json

4 June 2020

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27121479 AND SRC:MED&resulttype=core&format=json

4 June 2020

1262-1275

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27121479 AND SRC:MED&resulttype=core&format=json

4 June 2020

Nonsteroidal anti-inflammatory drugs and peptic ulcer disease

1 reference

https://api.crossref.org/works/10.1111/APT.13642

21 January 2018

Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1111/APT.13642

21 January 2018

Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study

1 reference

https://api.crossref.org/works/10.1111/APT.13642

21 January 2018

Guidelines for prevention of NSAID-related ulcer complications

1 reference

https://api.crossref.org/works/10.1111/APT.13642

21 January 2018

Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs.

1 reference

https://api.crossref.org/works/10.1111/APT.13642

21 January 2018

NSAID-associated deaths: the rise and fall of NSAID-associated GI mortality

1 reference

https://api.crossref.org/works/10.1111/APT.13642

21 January 2018

Increase in nonfatal digestive perforations and haemorrhages following introduction of selective NSAIDs: a public health concern

1 reference

https://api.crossref.org/works/10.1111/APT.13642

21 January 2018

The effectiveness of five strategies for the prevention of gastrointestinal toxicity induced by non-steroidal anti-inflammatory drugs: systematic review

1 reference

https://api.crossref.org/works/10.1111/APT.13642

21 January 2018

A comparison of the cost-effectiveness of five strategies for the prevention of non-steroidal anti-inflammatory drug-induced gastrointestinal toxicity: a systematic review with economic modelling

1 reference

https://api.crossref.org/works/10.1111/APT.13642

21 January 2018

Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation

1 reference

https://api.crossref.org/works/10.1111/APT.13642

21 January 2018

Endoscopic ulcers are neither meaningful nor validated as a surrogate for clinically significant upper gastrointestinal harm

1 reference

https://api.crossref.org/works/10.1111/APT.13642

21 January 2018

Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial.

1 reference

https://api.crossref.org/works/10.1111/APT.13642

21 January 2018

The relative efficacies of gastroprotective strategies in chronic users of nonsteroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1111/APT.13642

21 January 2018

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration

1 reference

https://api.crossref.org/works/10.1111/APT.13642

21 January 2018

Bias in meta-analysis detected by a simple, graphical test

1 reference

https://api.crossref.org/works/10.1111/APT.13642

21 January 2018

Mixed treatment comparison analysis provides internally coherent treatment effect estimates based on overviews of reviews and can reveal inconsistency

1 reference

https://api.crossref.org/works/10.1111/APT.13642

21 January 2018

Evidence synthesis for decision making 3: heterogeneity--subgroups, meta-regression, bias, and bias-adjustment

1 reference

https://api.crossref.org/works/10.1111/APT.13642

21 January 2018

Methodological problems in the use of indirect comparisons for evaluating healthcare interventions: survey of published systematic reviews

1 reference

https://api.crossref.org/works/10.1111/APT.13642

21 January 2018

Evidence synthesis for decision making 4: inconsistency in networks of evidence based on randomized controlled trials

1 reference

https://api.crossref.org/works/10.1111/APT.13642

21 January 2018

Effect of antisecretory drugs and nitrates on the risk of ulcer bleeding associated with nonsteroidal anti-inflammatory drugs, antiplatelet agents, and anticoagulants

1 reference

https://api.crossref.org/works/10.1111/APT.13642

21 January 2018

Proton-pump inhibitors are associated with a reduced risk for bleeding and perforated gastroduodenal ulcers attributable to non-steroidal anti-inflammatory drugs: a nested case-control study

1 reference

https://api.crossref.org/works/10.1111/APT.13642

21 January 2018

Dosage effects of histamine-2 receptor antagonist on the primary prophylaxis of non-steroidal anti-inflammatory drug (NSAID)-associated peptic ulcers: a retrospective cohort study

1 reference

https://api.crossref.org/works/10.1111/APT.13642

21 January 2018

Combination of a cyclo-oxygenase-2 inhibitor and a proton-pump inhibitor for prevention of recurrent ulcer bleeding in patients at very high risk: a double-blind, randomised trial.

1 reference

https://api.crossref.org/works/10.1111/APT.13642

21 January 2018

Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis

1 reference

https://api.crossref.org/works/10.1111/APT.13642

21 January 2018

Comparison of gastrointestinal adverse effects between cyclooxygenase-2 inhibitors and non-selective, non-steroidal anti-inflammatory drugs plus proton pump inhibitors: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1111/APT.13642

21 January 2018

Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis

1 reference

https://api.crossref.org/works/10.1111/APT.13642

21 January 2018

Double-blind randomized trials of single-tablet ibuprofen/high-dose famotidine vs. ibuprofen alone for reduction of gastric and duodenal ulcers

1 reference

https://api.crossref.org/works/10.1111/APT.13642

21 January 2018

Multinational, double-blind, randomised, placebo-controlled, prospective study of esomeprazole in the prevention of recurrent peptic ulcer in low-dose acetylsalicylic acid users: the LAVENDER study.

1 reference

https://api.crossref.org/works/10.1111/APT.13642

21 January 2018

Evidence synthesis for decision making 2: a generalized linear modeling framework for pairwise and network meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1111/APT.13642

21 January 2018

Network Meta-Analysis Comparing Relatively Selective COX-2 Inhibitors Versus Coxibs for the Prevention of NSAID-Induced Gastrointestinal Injury

1 reference

https://api.crossref.org/works/10.1111/APT.13642

21 January 2018

A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis

1 reference

https://api.crossref.org/works/10.1111/APT.13642

21 January 2018

Indirect Treatment Comparison/Network Meta-Analysis Study Questionnaire to Assess Relevance and Credibility to Inform Health Care Decision Making: An ISPOR-AMCP-NPC Good Practice Task Force Report

1 reference

https://api.crossref.org/works/10.1111/APT.13642

21 January 2018

Risk of upper gastrointestinal bleeding and perforation associated with Individual non-steroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1111/APT.13642

21 January 2018

Identifiers

10.1111/APT.13642

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27121479 AND SRC:MED&resulttype=core&format=json

4 June 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27121479 AND SRC:MED&resulttype=core&format=json

4 June 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36001198&oldid=1973391680"